{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:57:45Z","timestamp":1788541065495,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Special Fund for Health Development Research of Beijing","award":["2024-2G-30121"],"award-info":[{"award-number":["2024-2G-30121"]}]},{"name":"the High-level Public Health Talent Development Program of Beijing","award":["Discipline Backbone-02-12"],"award-info":[{"award-number":["Discipline Backbone-02-12"]}]},{"name":"the High-level Public Health Talent Development Program of Beijing","award":["Discipline Leader-01-09"],"award-info":[{"award-number":["Discipline Leader-01-09"]}]},{"name":"National Key Research and Development Program of China","award":["2023YFC2308703"],"award-info":[{"award-number":["2023YFC2308703"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-10952-0","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T03:09:47Z","timestamp":1745377787000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Coinfection of hepatitis B, tuberculosis, and HIV\/AIDS in Beijing from 2016 to 2023: a surveillance data analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Chao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaze","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"issue":"2","key":"10952_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.19914\/j.cjvi.2018.02.001","volume":"24","author":"GM Zhang","year":"2018","unstructured":"Zhang GM, Miao N, Zheng H, Sun XJ, Yin ZD, Wang FZ. Incidence by age and region of hepatitis B reported in China from 2005 to 2016. Chin J Vaccin Immun. 2018;24(2):121\u20136. https:\/\/doi.org\/10.19914\/j.cjvi.2018.02.001. (InChinese).","journal-title":"Chin J Vaccin Immun"},{"key":"10952_CR2","unstructured":"Li TW. Spatio-temporal analysis of pulmonary tuberculosis and research on atmospheric environmental risk factors from 2004 to 2017 in China[Master\u2019s thesis]. Hunan Normal University. 2021. https:\/\/link.oversea.cnki.net\/doi\/10.27137\/d.cnki.ghusu.2021.002555. (In Chinese)."},{"issue":"03","key":"10952_CR3","doi-asserted-by":"publisher","first-page":"247","DOI":"10.13419\/j.cnki.aids.2023.03.01","volume":"29","author":"MJ Han","year":"2023","unstructured":"Han MJ. Analysis of the Epidemic Situation and Prospects for Prevention and Control of HIV\/AIDS in China. Chin J AIDS STD. 2023;29(03):247\u201350. https:\/\/doi.org\/10.13419\/j.cnki.aids.2023.03.01. (InChinese).","journal-title":"Chin J AIDS STD"},{"key":"10952_CR4","unstructured":"National Health Commission of the People\u2019s Republic of China. Technical Guidelines for Tuberculosis Prevention and Control in China (2020) [guideline]. [cited 2024 Octuber 8]. Available from: https:\/\/tb.chinacdc.cn\/ggl\/202004\/P020200414515703939844.pdf .(In Chinese)."},{"key":"10952_CR5","doi-asserted-by":"publisher","unstructured":"Chinese Society of Infectious Disease, Chinese Society of Hepatology, Chinese Medical Association. Expert consensus on clinical cure (functional cure) of chronic hepatitis B. Chin J Infect Dis. 2019;37(08):461\u201372. https:\/\/doi.org\/10.3969\/j.issn.1001-5256.2019.08.008. (In Chinese).","DOI":"10.3969\/j.issn.1001-5256.2019.08.008"},{"issue":"11","key":"10952_CR6","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.13419\/j.cnki.aids.2021.11.02","volume":"27","author":"Chinese Society of Infectious Disease","year":"2021","unstructured":"Chinese Society of Infectious Disease. Chinese Guidelines for the Diagnosis and Treatment of AIDS. Chin J AIDS STD. 2021;27(11):1182\u2013201. https:\/\/doi.org\/10.13419\/j.cnki.aids.2021.11.02. (InChinese).","journal-title":"Chin J AIDS STD"},{"issue":"3","key":"10952_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/QCO.0000000000000447","volume":"31","author":"AJ McArdle","year":"2018","unstructured":"McArdle AJ, Turkova A, Cunnington AJ. When do co-infections matter? Curr Opin Infect Dis. 2018;31(3):209\u201315. https:\/\/doi.org\/10.1097\/QCO.0000000000000447.","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"10952_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12985-020-01385-z","volume":"17","author":"BE Feleke","year":"2020","unstructured":"Feleke BE, Feleke TE, Adane WG, Girma A. Impacts of hepatitis B and hepatitis C co-infection with tuberculosis, a prospective cohort study. Virol J. 2020;17(1):113. https:\/\/doi.org\/10.1186\/s12985-020-01385-z.","journal-title":"Virol J"},{"issue":"11","key":"10952_CR9","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.19485\/j.cnki.issn2096-5087.2022.11.009","volume":"34","author":"GX Sang","year":"2022","unstructured":"Sang GX, Chen T, Che Y, Chen YP, He TF. Screening of Mycobacterium Tuberculosis and HIV co-infection in Ningbo City. Prev Med. 2022;34(11):1121\u20134. https:\/\/doi.org\/10.19485\/j.cnki.issn2096-5087.2022.11.009. (In Chinese).","journal-title":"Prev Med."},{"issue":"1","key":"10952_CR10","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1186\/s12879-023-08575-4","volume":"23","author":"CC Qi","year":"2023","unstructured":"Qi CC, Xu LR, Zhao CJ, Zhang HY, Li QY, Liu MJ, Zhang YX, Tang Z, Ma XX. Prevalence and risk factors of tuberculosis among people living with HIV\/AIDS in China: a systematic review and meta-analysis. BMC Infect Dis. 2023;23(1):584. https:\/\/doi.org\/10.1186\/s12879-023-08575-4.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10952_CR11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3760\/cma.j.cn112338-20200727-00987","volume":"42","author":"Y Cao","year":"2021","unstructured":"Cao Y, Zhou MH, Zhai XJ. Prevalence of HBV co-infection in HIV-positive population in China: a systematic review and Meta-analysis. Chin J Epidemiol. 2021;42(2):327\u201334. https:\/\/doi.org\/10.3760\/cma.j.cn112338-20200727-00987. (InChinese).","journal-title":"Chin J Epidemiol"},{"issue":"5","key":"10952_CR12","doi-asserted-by":"publisher","first-page":"e10736","DOI":"10.1371\/journal.pone.0010736","volume":"5","author":"L Gao","year":"2010","unstructured":"Gao L, Zhou F, Li X, Jin Q. HIV\/TB co-infection in mainland China: a meta-analysis. PLoS ONE. 2010;5(5):e10736. https:\/\/doi.org\/10.1371\/journal.pone.0010736.","journal-title":"PLoS ONE"},{"issue":"22","key":"10952_CR13","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.3969\/j.issn.1003-8507.2008.22.070","volume":"35","author":"JG Xu","year":"2008","unstructured":"Xu JG, Wang RT, Yuan ZH. Investigation on the Incidence of HIV, Syphilis and HBV among the Tuberculosis Patients. Modern Prev Med. 2008;35(22):4495\u20137. https:\/\/doi.org\/10.3969\/j.issn.1003-8507.2008.22.070. (InChinese).","journal-title":"Modern Prev Med"},{"issue":"01","key":"10952_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3969\/j.issn.2095-6584.2018.01.023","volume":"17","author":"QZ Sun","year":"2018","unstructured":"Sun QZ, Fan MK, Liu XM, Yuan X. Investigation on the status of co-infection of hepatitis B virus in tuberculosis patients. J Xiang Yang Voc Tech College. 2018;17(01):88\u201390. https:\/\/doi.org\/10.3969\/j.issn.2095-6584.2018.01.023. (InChinese).","journal-title":"J Xiang Yang Voc Tech College"},{"issue":"5","key":"10952_CR15","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/ijc.33313","volume":"148","author":"JF Shi","year":"2021","unstructured":"Shi JF, Cao M, Wang Y, Bai FZ, Lei L, Peng J, Feletto E, Canfell K, Qu C, Chen W. Is it possible to halve the incidence of liver cancer in China by 2050? Int J Cancer. 2021;148(5):1051\u201365. https:\/\/doi.org\/10.1002\/ijc.33313.","journal-title":"Int J Cancer"},{"issue":"Suppl 9","key":"10952_CR16","doi-asserted-by":"publisher","first-page":"J8","DOI":"10.1016\/j.vaccine.2012.12.019","volume":"31","author":"X Liang","year":"2013","unstructured":"Liang X, Cui F, Hadler S, Wang X, Luo H, Chen Y, Kane M, Shapiro C, Yang W, Wang Y. Origins, design and implementation of the China GAVI project. Vaccine. 2013;31(Suppl 9):J8\u201314. https:\/\/doi.org\/10.1016\/j.vaccine.2012.12.019.","journal-title":"Vaccine"},{"issue":"1","key":"10952_CR17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2471\/BLT.14.139626","volume":"93","author":"AL Wang","year":"2015","unstructured":"Wang AL, Qiao YP, Wang LH, Fang LW, Wang F, Jin X, Qiu J, Wang XY, Wang Q, Wu JL, Vermund SH, Song L. Integrated prevention of mother-to-child transmission for human immunodeficiency virus, syphilis and hepatitis B virus in China. Bull World Health Organ. 2015;93(1):52\u20136. https:\/\/doi.org\/10.2471\/BLT.14.139626.","journal-title":"Bull World Health Organ"},{"key":"10952_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.19914\/j.cjvi.2015.03.011","volume":"21","author":"J Cui","year":"2015","unstructured":"Cui J, Cao L, Zheng JS, Cao LS, Yuan P, Li L. Coverage analysis of national immunization program vaccine reported in China, 2013. Chin J Vaccines Immun. 2015;21:289\u201395. https:\/\/doi.org\/10.19914\/j.cjvi.2015.03.011. (InChinese).","journal-title":"Chin J Vaccines Immun"},{"issue":"43","key":"10952_CR19","doi-asserted-by":"publisher","first-page":"6444","DOI":"10.1016\/j.vaccine.2023.08.015","volume":"41","author":"WY Ji","year":"2023","unstructured":"Ji WY, Liu DL, Yu R, Miao L, Yuan QL, Suo LD, Yu JP. Vaccination coverage survey of children aged 1\u20133 years in Beijing China, 2005-2021. Vaccine. 2023;41(43):6444\u201352. https:\/\/doi.org\/10.1016\/j.vaccine.2023.08.015.","journal-title":"Vaccine"},{"issue":"5","key":"10952_CR20","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/PHH.0000000000001536","volume":"28","author":"RJ Wong","year":"2022","unstructured":"Wong RJ, Kaufman HW, Niles JK, Meyer WA 3rd, Chitnis AS. Prevalence of Hepatitis B Virus and Latent Tuberculosis Coinfection in the United States. J Public Health Manag Pract. 2022;28(5):452\u201362. https:\/\/doi.org\/10.1097\/PHH.0000000000001536.","journal-title":"J Public Health Manag Pract"},{"issue":"9","key":"10952_CR21","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1007\/s00705-020-04716-1","volume":"165","author":"R Rashti","year":"2020","unstructured":"Rashti R, Alavian SM, Moradi Y, Sharafi H, Mohamadi Bolbanabad A, Roshani D, Moradi G. Global prevalence of HCV and\/or HBV coinfections among people who inject drugs and female sex workers who live with HIV\/AIDS: a systematic review and meta-analysis. Arch Virol. 2020;165(9):1947\u201358. https:\/\/doi.org\/10.1007\/s00705-020-04716-1.","journal-title":"Arch Virol"},{"issue":"1","key":"10952_CR22","doi-asserted-by":"publisher","first-page":"13542","DOI":"10.1038\/s41598-021-92688-w","volume":"11","author":"A Mukhatayeva","year":"2021","unstructured":"Mukhatayeva A, Mustafa A, Dzissyuk N, Issanov A, Bayserkin B, Vermund SH, Ali S. Hepatitis B, Hepatitis C, tuberculosis and sexually-transmitted infections among HIV positive patients in Kazakhstan. Sci Rep. 2021;11(1):13542. https:\/\/doi.org\/10.1038\/s41598-021-92688-w.","journal-title":"Sci Rep"},{"issue":"4","key":"10952_CR23","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/S2468-1253(23)00321-7","volume":"9","author":"GS Cooke","year":"2024","unstructured":"Cooke GS, Flower B, Cunningham E, Marshall AD, Lazarus JV, Palayew A, Jia J, Aggarwal R, Al-Mahtab M, Tanaka Y, Jeong SH, Poovorawan K, Waked I, Hiebert L, Khue PM, Grebely J, Alcantara-Payawal D, Sanchez-Avila JF, Mbendi C, Muljono DH, Lesi O, Desalegn H, Hamid S, de Araujo A, Cheinquer H, Onyekwere CA, Malyuta R, Ivanchuk I, Thomas DL, Pimenov N, Chulanov V, Dirac MA, Han H, Ward JW. Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update. Lancet Gastroenterol Hepatol. 2024;9(4):346\u201365. https:\/\/doi.org\/10.1016\/S2468-1253(23)00321-7.","journal-title":"Lancet Gastroenterol Hepatol."},{"issue":"14","key":"10952_CR24","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1097\/QAD.0b013e328355ced2","volume":"26","author":"H Wang","year":"2012","unstructured":"Wang H, Li Y, Zhang C, Han Y, Zhang X, Zhu T, Li T. Immunological and virological responses to cART in HIV\/HBV co-infected patients from a multicenter cohort. AIDS. 2012;26(14):1755\u201363. https:\/\/doi.org\/10.1097\/QAD.0b013e328355ced2.","journal-title":"AIDS"},{"issue":"11","key":"10952_CR25","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/S1473-3099(14)70946-6","volume":"14","author":"F Zhang","year":"2014","unstructured":"Zhang F, Zhu H, Wu Y, Dou Z, Zhang Y, Kleinman N, Bulterys M, Wu Z, Ma Y, Zhao D, Liu X, Fang H, Liu J, Cai WP, Shang H. HIV, hepatitis B virus, and hepatitis C virus co-infection in patients in the China National Free Antiretroviral Treatment Program, 2010\u201312: a retrospective observational cohort study. Lancet Infect Dis. 2014;14(11):1065\u201372. https:\/\/doi.org\/10.1016\/S1473-3099(14)70946-6.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10952_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.mcna.2023.10.004","volume":"108","author":"S Tuddenham","year":"2024","unstructured":"Tuddenham S. Sexually Transmitted Infections. Med Clin North Am. 2024;108(2):66. https:\/\/doi.org\/10.1016\/j.mcna.2023.10.004.","journal-title":"Med Clin North Am."},{"issue":"04","key":"10952_CR27","doi-asserted-by":"publisher","first-page":"339","DOI":"10.13419\/j.cnki.aids.2024.04.02","volume":"30","author":"WY Lin","year":"2024","unstructured":"Lin WY. Expert consensus on the diagnosis and treatment of HIV combined with HBV and HCV infections in China. Chin J AIDS & STD. 2024;30(04):339\u201346. https:\/\/doi.org\/10.13419\/j.cnki.aids.2024.04.02. (InChinese).","journal-title":"Chin J AIDS & STD"},{"issue":"01","key":"10952_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.16760\/j.cnki.sdggws.2024.01.005","volume":"18","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Li G, Shi YP, Wang C, Liu Y, Hu X, Li W, Li JZ, Gao YL. Epidemiological trends and features of blood-borne and sexually transmitted notifiable diseases in Beijing, 2017-2022. Capital J Public Health. 2024;18(01):41\u20135. https:\/\/doi.org\/10.16760\/j.cnki.sdggws.2024.01.005. (In Chinese).","journal-title":"Capital J Public Health."},{"key":"10952_CR29","unstructured":"Chinese Center for Disease Control and Prevention, National Center for AIDS\/STD Control and Prevention. Guidelines for Follow up Work of AIDS Virus Infected Persons (2016 Edition)[guideline]. [cited 2024 Octuber 8]. Available from: https:\/\/www.jzcdc.cn\/uploads\/allimg\/20220812\/3-220Q2092510963.pdf. In Chinese)."},{"issue":"30","key":"10952_CR30","doi-asserted-by":"publisher","first-page":"559","DOI":"10.46234\/ccdcw2020.150","volume":"2","author":"N Miao","year":"2020","unstructured":"Miao N, Zheng H, Sun X, Wang F, Zhang G, Yin Z. Acute Hepatitis B - China, 2005\u20132019. China CDC Wkly. 2020;2(30):559\u201363. https:\/\/doi.org\/10.46234\/ccdcw2020.150.","journal-title":"China CDC Wkly"},{"issue":"05","key":"10952_CR31","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3969\/j.issn.1672-5166.2024.05.01","volume":"21","author":"ZX Zhao","year":"2024","unstructured":"Zhao ZX, Ma JQ. Application and Progress of Digital and Intelligent Infectious Disease Prevention and Control. Chin J Health Inform Manag. 2024;21(05):635\u201340. https:\/\/doi.org\/10.3969\/j.issn.1672-5166.2024.05.01.","journal-title":"Chin J Health Inform Manag"},{"issue":"7","key":"10952_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.16506\/j.1009-6639.2024.07.001","volume":"25","author":"EF Chen","year":"2024","unstructured":"Chen EF, Cui FQ, Dang SS, Hung Y, Lei XZ, Li ZC, Lin BL, Liu J, Peng J, Shi L, Wang H, Wu B, Zhang SQ, Zhang Y, Zhao H, Zhu YY. Expert recommendations for screening, testing, and management of adult hepatitis B virus infection. Chin Prev Med. 2024;25(7):1\u20139. https:\/\/doi.org\/10.16506\/j.1009-6639.2024.07.001.(InChinese)","journal-title":"Chin Prev Med"},{"key":"10952_CR33","unstructured":"Chinese Center for Disease Control and Prevention. The Technical Guidelines for the Management of Infectious Disease Information Reporting in China (2016 edition)[guideline].[cited 2024 Octuber 8]. Available from: https:\/\/tb.chinacdc.cn\/xzf\/fgznan\/202405\/P020240516526531726979.pdf . (in Chinese)."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10952-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10952-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10952-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T03:10:01Z","timestamp":1745377801000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10952-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10952"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10952-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"20 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is based on non-anonymized data from the infectious disease reporting system, but there are no conflicts of interest between any of the authors and the individuals in the data and only the data analysts have access to the non-anonymized data. The study has been approved by the Ethics Committee (Ethical Review Committee of the Beijing Center for Disease Prevention and Control, ethical approval notification number: 2023D []. In accordance with the provisions of the 'Infectious Disease Law of the People's Republic of China' and the 'Infectious Disease Reporting Management Regulations', the requirement for informed consent was waived for this study.The study was conducted in compliance with the ethical principles outlined in the Declaration of Helsinki. Specifically, the research was designed and conducted to respect the rights, dignity, and well-being of the participants, and the waiver of informed consent was justified given the nature of the data and the regulatory framework governing infectious disease reporting. The study also adhered to the principles of minimizing harm and ensuring the confidentiality of personal information.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"584"}}